Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.31 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17405528 | 0.98 | ESR2 (0.36) | ESR2ESR1GPR3ALDH1A1LMNA | |
| SCHEMBL16275367 | 0.95 | ESR2 (0.36) | ESR2ESR1GPR3ALDH1A1LMNA | |
| SCHEMBL19986070 | 0.94 | ESR2 (0.35) | ESR2ESR1GPR3ALDH1A1LMNA | |
| SCHEMBL17246241 | 0.93 | ESR2 (0.36) | ESR2ESR1GPR3ALDH1A1LMNA | |
| SCHEMBL17405729 | 0.93 | ESR2 (0.36) | ESR2ESR1GPR3ALDH1A1LMNA | |
| SCHEMBL17405926 | 0.92 | ALDH1A1 (0.34) | ESR2ESR1GPR3ALDH1A1LMNA | |
| SCHEMBL17406094 | 0.92 | ALDH1A1 (0.36) | ESR2ESR1GPR3ALDH1A1LMNA | |
| SCHEMBL17405328 | 0.92 | ALDH1A1 (0.36) | ESR2ESR1GPR3ALDH1A1LMNA | |
| SCHEMBL17406184 | 0.92 | ALDH1A1 (0.34) | ESR2ESR1GPR3ALDH1A1LMNA | |
| SCHEMBL17405671 | 0.91 | ESR2 (0.38) | ESR2ESR1GPR3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9887367-B2 | Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-06 | — | — | US | disclosed |
| US-9887367-B2 | Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-06 | — | — | US | disclosed |
| US-20160005977-A1 | HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
| US-20160005977-A1 | HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160005977-A1 | HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE | ODC1, NOTUM, OR10J3 | ESR2 331/4885ESR1 29/4885GPR3 4592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.